A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
Condition(s):Neoplasms; Solid Tumor, Adult; Non-Hodgkin Lymphoma; Myelodysplastic SyndromesLast Updated:February 28, 2024Active, not recruiting